glp 1 vs fasting GLP-1 receptor agonists Fasting VS. GLP-1s - Burn
Description
Data are representative of 3 experiments
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
Journal of immunology (Baltimore, Md: 1950) 2008;181:4780-90
We conduct a thorough assessment of each patient's health history, weight loss goals, and any existing medical conditions to determine if weight loss medication is an appropriate and beneficial option for them
Hazard ratio, 0.78 (95% CI, 0.66-0.93)
Now were moving to 15% total body weight loss
